Pharmafile Logo
Pharmafocus logo
Advanced Search

joint venture

Showing 5 posts of 5 posts found.

amgen_hq

Kirin Holdings to withdraw from 30 year venture with Amgen, sell shares for $780m

October 31, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Kirin, joint venture, pharma

Japanese firm Kirin Holdings has announced its intention to withdraw from a joint research collaboration with Amgen, saying it would …

News
takeda

Takeda, Teva name Hiroshi Matsumori CEO of Japanese generic drug joint venture

April 4, 2016
Business Services, Sales and Marketing CEO Appointment, Takeda, Teva, joint venture

Japanese drug firm Takeda (TYO: 4502) and Israel-based Teva (NYSE: TEVA) named Hiroshi Matsumori the chief executive for their newly-formed …

Appointment
Researcher

Big pharma and UK universities launch £40m innovation fund

January 25, 2016
Research and Development, Sales and Marketing Apollo, AstraZeneca, GSK, GlaxoSmithKline, Johnson & Johson, UCL, University College London, University of Cambridge, collaboration, imperial college london, joint venture

A consortium of big pharma companies and university with world-leading medical research facilities is to invest £40 million, to “significantly …

News
6123892769_1befc31f38_o

GSK ‘in discussions’ over $1 billion tech deal with Qualcomm

January 21, 2016
Medical Communications GSK, beyond the pill, digital pharma, joint venture, qualcomm

GlaxoSmithKline and telecoms giant Qualcomm are reportedly discussing a joint venture agreement worth as much as $1 billion, as the …

News

Takeda and Teva set out generics joint venture plan

January 4, 2016
Sales and Marketing Takeda, Teva, generics, joint venture

Takeda and Teva have detailed plans for a new joint venture to create a new company to market off-patent generic …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025